SCHEMBL1492687

SCHEMBL1492687

COc1ccc(-c2ccccc2)cc1NC(=O)Nc1ccc(-c2ccnc(C)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PORCN Q9H237 2/20 0.60
MEN1 O00255 2/20 0.58
MAPT P10636 2/20 0.58
KMT2A Q03164 2/20 0.58
ALDH1A1 P00352 1/20 0.58
PSEN1 P49768 5/20 0.57
PSEN2 P49810 5/20 0.57
APH1B Q8WW43 5/20 0.57
NCSTN Q92542 5/20 0.57
APH1A Q96BI3 5/20 0.57
PSENEN Q9NZ42 5/20 0.57
WNT3A P56704 1/20 0.57
IDO1 P14902 8/20 0.56
TP53 P04637 1/20 0.51
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
RUVBL1 Q9Y265 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492989 0.91 SMN1; SMN2 (0.62) PORCNMEN1MAPTKMT2AALDH1A1
SCHEMBL1492820 0.90 MAPT (0.65) MEN1MAPTKMT2AALDH1A1PSEN1
SCHEMBL1493084 0.88 MEN1 (0.58) MEN1MAPTKMT2APSEN1PSEN2
SCHEMBL1492881 0.88 PSEN1 (0.56) PORCNMEN1MAPTKMT2AALDH1A1
SCHEMBL1492785 0.86 PSEN1 (0.57) MEN1MAPTKMT2APSEN1PSEN2
SCHEMBL1492973 0.85 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1493028 0.84 PSEN1 (0.68) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492866 0.83 MEN1 (0.61) PORCNMEN1MAPTKMT2APSEN1
SCHEMBL1492879 0.83 PSEN1 (0.61) PORCNPSEN1PSEN2APH1BNCSTN
SCHEMBL1492788 0.82 HTR2C (0.57) PORCNMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PORCN 3166/4885MEN1 3122/4885MAPT 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.